Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-004122
Filing Date
2017-05-10
Accepted
2017-05-10 16:16:12
Documents
67
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q immu-20170331x10q.htm 10-Q 1589345
2 EX-10.1 immu-20170331ex101f3ddf9.htm EX-10.1 917634
3 EX-10.2 immu-20170331ex1022706c0.htm EX-10.2 195317
4 EX-31.1 immu-20170331ex31162d8d0.htm EX-31.1 15281
5 EX-31.2 immu-20170331ex3123f0530.htm EX-31.2 16157
6 EX-32.1 immu-20170331ex321b4b1fa.htm EX-32.1 12282
7 GRAPHIC immu20170331ex101f3ddf9001.jpg GRAPHIC 4776
8 GRAPHIC immu20170331ex101f3ddf9002.jpg GRAPHIC 3760
  Complete submission text file 0001558370-17-004122.txt   7904557

Data Files

Seq Description Document Type Size
9 EX-101.INS immu-20170331.xml EX-101.INS 1594125
10 EX-101.SCH immu-20170331.xsd EX-101.SCH 40423
11 EX-101.CAL immu-20170331_cal.xml EX-101.CAL 46248
12 EX-101.DEF immu-20170331_def.xml EX-101.DEF 170693
13 EX-101.LAB immu-20170331_lab.xml EX-101.LAB 374795
14 EX-101.PRE immu-20170331_pre.xml EX-101.PRE 327723
Mailing Address 300 AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address 300 AMERICAN RD MORRIS PLAINS NJ 07950 9736058200
IMMUNOMEDICS INC (Filer) CIK: 0000722830 (see all company filings)

EIN.: 611009366 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-12104 | Film No.: 17830451
SIC: 2835 In Vitro & In Vivo Diagnostic Substances